-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/cmJ4Bm9BysHuBX2Wy8MQbc
December 07, 2005 - Screening for Speech and Language Delay in Preschool Children: Systematic Evidence Review
1
Screening for Speech and Language Delay in Preschool Children: Systematic Evidence
Review for the US Preventive Services Task Force
Heidi D. Nelson, MD, MPH (1, 2, 4)
Peggy Nygren, MA (1, 4)
Miranda Walker, B…
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/aspirin-for-the-prevention-of-cardiovascular-disease-preventive-medication-2009
March 15, 2009 - Share to Facebook
Share to X
Share to WhatsApp
Share to Email
Print
archived
Final Recommendation Statement
Aspirin for the Prevention of Cardiovascular Disease: Preventive Medication
March 15, 2009
Recommendations made by the USPSTF ar…
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/-hnLT26c2NHs6thK9yznPF
July 01, 2002 - At present, the most commonly used tool
for calculating risk of developing breast cancer is the
Gail … The National Cancer Institute (NCI) used the
Gail model to develop a breast cancer risk
assessment calculating
-
www.uspreventiveservicestaskforce.org/uspstf/document/reducing-risk-for-mother-to-infant-transmission-of-hepatitis-c-virus-a-systematic-review-for-the-us-preventive-services-task-force/hepatitis-c-screening-2013
November 15, 2012 - Share to Facebook
Share to X
Share to WhatsApp
Share to Email
Print
archived
Reducing Risk for Mother-to-Infant Transmission of Hepatitis C Virus: A Systematic Review for the U.S. Preventive Services Task Force
Hepatitis C: Screening
November …
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/cTa7Hs56-yj4kCr7yXLdRm
July 01, 1994 - When calculating summary estimates of sensitivity and
specificity, we included only studies that had
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/human-immunodeficiency-virus-hiv-infection-screening-2005
July 05, 2005 - Methods for Calculating Relative Risk for Clinical Progression or Death during HAART Compared to No Treatment … Methods for Calculating 3-Year Risk for Cardiovascular Complications
The background rate (cases per
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/4fdC2JLwP_um_yZe4WZRaa
April 01, 2009 - Using Aspirin for the Primary Prevention of Cardiovascular Disease
How do I determine benefit?
An individual’s potential clinical benefit
from aspirin depends on his or her
baseline risk.
MI Risk Factors for Men
y Age
y Diabetes
y Total cholesterol level
y HDL cholesterol level
y High blood pressure
y Smok…
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/healthy-diet-and-physical-activity-counseling-for-cvd-prevention-in-adults-2012
June 15, 2012 - Share to Facebook
Share to X
Share to WhatsApp
Share to Email
Print
archived
Final Recommendation Statement
Healthy Diet and Physical Activity: Counseling for CVD Prevention in Adults
June 15, 2012
Recommendations made by the USPSTF …
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/n6zHNuxCoZRTdKJ_m2JFtU
July 07, 2009 - Screening For Impaired Visual Acuity In Older Adults: Clinical Summary
SCREENING FOR IMPAIRED VISUAL ACUITY IN OLDER ADULTS*
CLINICAL SUMMARY OF U.S. PREVENTIVE TASK FORCE RECOMMENDATION
Population
Adults Age 65 and Older
Recommendation
Grade I: Insufficient Evidence
Ris…
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/screening-for-prediabetes-and-type-2-diabetes
November 15, 2018 - Share to Facebook
Share to X
Share to WhatsApp
Share to Email
Print
Final Research Plan
Prediabetes and Type 2 Diabetes: Screening
November 15, 2018
Recommendations made by the USPSTF are independent of the U.S. government. They should not be …
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/Z-PbjsHwm4jWMadqNh9Pbz
Screening for and Management of Obesity in Adults: Clinical Summary of USPSTF Recommendation
SCREENING FOR AND MANAGEMENT OF OBESITY IN ADULTS
CLINICAL SUMMARY OF U.S. PREVENTIVE SERVICES TASK FORCE RECOMMENDATION
Population
Adults aged 18 years or older
Recommendation
Screen for obesity. Pat…
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/5V8t2G6kCTJU6fLBHnfTuR
January 01, 2013 - Reducing Risk for Mother-to-Infant Transmission of Hepatitis C Virus: A Systematic Review for the USPSTF
Reducing Risk for Mother-to-Infant Transmission of Hepatitis C Virus:
A Systematic Review for the U.S. Preventive Services Task Force
Erika Barth Cottrell, PhD, MPP; Roger Chou, MD; Ngoc Wasson, MPH; Basmah Rahman…
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/oXCNxbeXh-ZSDuEUzz6UQ8
Clinical Summary: Behavioral Weight Loss Interventions to Prevent Obesity-Related Morbidity and Mortality in Adults
Clinical Summary: Behavioral Weight Loss Interventions to Prevent Obesity-Related Morbidity and Mortality in Adults
Population Adults w ith a BMI ≥30a
Recommendation
Offer or refer to i…
-
www.uspreventiveservicestaskforce.org/uspstf/about-uspstf/methods-and-processes/procedure-manual/procedure-manual-appendix-viii-standardization-outcome-tables
July 01, 2017 - Procedure Manual Appendix VIII. Standardization of Outcome Tables
Share to Facebook
Share to X
Share to WhatsApp
Share to Email
Print
Although it is not possible to completely standardize outcomes tables because of the diversity of issues amo…
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/WzcBGop2UHqGdxk9y_PMF-
Screening for Lipid Disorders in Children and Adolescents: Clinical Summary
Figure. Screening for Lipid Disorders in Children and Adolescents: Clinical Summary
Population Asymptomatic children and adolescents 20 years or younger
Recommendation
No recommendation.
Grade: I (insufficient evidence)
…
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/syphilis-infection-nonpregnant-adults-adolescents-screening
September 27, 2022 - Share to Facebook
Share to X
Share to WhatsApp
Share to Email
Print
Evidence Summary
Syphilis Infection in Nonpregnant Adolescents and Adults: Screening
September 27, 2022
Recommendations made by the USPSTF are independent of the U.S. governmen…
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/3qpQqeeozW8nV3a4_BWntp
June 20, 2019 - Methods for Calculating Relative Risk for Clinical
Progression or Death during HAART Compared with No … Methods for Calculating 3-Year Risk for Cardiovascular
Complications
The background rate (cases per
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/Z3BVaJRtyu8drWSHWYT_Yf
Clinical Summary: Medication Use to Reduce Risk of Breast Cancer
Clinical Summary: Medication Use to Reduce Risk of Breast Cancer
Population Women aged ≥35 y at increased risk for breast cancer Women aged ≥35 y not at increased risk for breast cancer
Recommendation
Offer to prescribe risk-reducing medicati…
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/breast-and-ovarian-cancer-brca-testing-screening-2005
September 15, 2005 - On the use of familial aggregation in population-based case probands for calculating penetrance. … positive family history is present,
We conducted a sensitivity analysis in the average-risk groups by calculating
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/h-FnuqpAKFeMyTDcr_m9tS
Aspirin Use for the Primary Prevention of Cardiovascular Disease and Colorectal Cancer: Clinical Summary
Figure. Aspirin Use for the Primary Prevention of Cardiovascular Disease and Colorectal Cancer: Clinical Summary
Population Adults aged 50 to 59 y with a
≥10% 10-y CVD risk
Adults aged 60 to 69 y with a …